Dnaprint Genomics Stock Market Value
DNAPrint Genomics' market value is the price at which a share of DNAPrint Genomics trades on a public exchange. It measures the collective expectations of DNAPrint Genomics investors about its performance. With this module, you can estimate the performance of a buy and hold strategy of DNAPrint Genomics and determine expected loss or profit from investing in DNAPrint Genomics over a given investment horizon. Check out DNAPrint Genomics Correlation, DNAPrint Genomics Volatility and DNAPrint Genomics Performance module to complement your research on DNAPrint Genomics. For more detail on how to invest in DNAPrint Stock please use our How to Invest in DNAPrint Genomics guide.
| Symbol | DNAPrint |
Can Biotechnology industry sustain growth momentum? Does DNAPrint have expansion opportunities? Factors like these will boost the valuation of DNAPrint Genomics. Projected growth potential of DNAPrint fundamentally drives upward valuation adjustments. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating DNAPrint Genomics demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
The market value of DNAPrint Genomics is measured differently than its book value, which is the value of DNAPrint that is recorded on the company's balance sheet. Investors also form their own opinion of DNAPrint Genomics' value that differs from its market value or its book value, called intrinsic value, which is DNAPrint Genomics' true underlying value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Because DNAPrint Genomics' market value can be influenced by many factors that don't directly affect DNAPrint Genomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between DNAPrint Genomics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding DNAPrint Genomics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, DNAPrint Genomics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
DNAPrint Genomics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to DNAPrint Genomics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of DNAPrint Genomics.
| 11/17/2025 |
| 02/15/2026 |
If you would invest 0.00 in DNAPrint Genomics on November 17, 2025 and sell it all today you would earn a total of 0.00 from holding DNAPrint Genomics or generate 0.0% return on investment in DNAPrint Genomics over 90 days. DNAPrint Genomics, Inc. engages in the development and marketing of genetic testing products and services More
DNAPrint Genomics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure DNAPrint Genomics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess DNAPrint Genomics upside and downside potential and time the market with a certain degree of confidence.
DNAPrint Genomics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for DNAPrint Genomics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as DNAPrint Genomics' standard deviation. In reality, there are many statistical measures that can use DNAPrint Genomics historical prices to predict the future DNAPrint Genomics' volatility.DNAPrint Genomics Backtested Returns
We have found zero technical indicators for DNAPrint Genomics, which you can use to evaluate the volatility of the firm. The firm owns a Beta (Systematic Risk) of 0.0, which means not very significant fluctuations relative to the market. the returns on MARKET and DNAPrint Genomics are completely uncorrelated.
Auto-correlation | 0.00 |
No correlation between past and present
DNAPrint Genomics has no correlation between past and present. Overlapping area represents the amount of predictability between DNAPrint Genomics time series from 17th of November 2025 to 1st of January 2026 and 1st of January 2026 to 15th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of DNAPrint Genomics price movement. The serial correlation of 0.0 indicates that just 0.0% of current DNAPrint Genomics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out DNAPrint Genomics Correlation, DNAPrint Genomics Volatility and DNAPrint Genomics Performance module to complement your research on DNAPrint Genomics. For more detail on how to invest in DNAPrint Stock please use our How to Invest in DNAPrint Genomics guide.You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
DNAPrint Genomics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.